IV.9 Haematological complications
Publication year - 2002
Publication title -
nephrology dialysis transplantation
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/17.suppl_4.48
Subject(s) - medicine , azathioprine , transplantation , intensive care medicine , pediatrics , disease
A. Because anaemia is relatively common after kidney transplantation, regular screening and careful evaluation of its causes are recommended. In many cases, post-transplant anaemia is caused by allograft dysfunction. The use of purine synthesis inhibitors (azathioprine and MMF), ACE inhibitors and angiotensin II receptor antagonists may frequently cause post-transplant anaemia. Anaemia is reversible after withdrawing the offending agent. Haemolytic anaemia may develop in transplant recipients. B. Treatment of anaemia should follow the European best practice guidelines for treatment of anaemia in chronic renal failure.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom